Nothing Special   »   [go: up one dir, main page]

JPS5732226A - Substance capable of preventing suppuration and aggravation by direct application to affected part just after surgical operation or exodontia or exposed affected part of external wound or athlete's foot - Google Patents

Substance capable of preventing suppuration and aggravation by direct application to affected part just after surgical operation or exodontia or exposed affected part of external wound or athlete's foot

Info

Publication number
JPS5732226A
JPS5732226A JP10677280A JP10677280A JPS5732226A JP S5732226 A JPS5732226 A JP S5732226A JP 10677280 A JP10677280 A JP 10677280A JP 10677280 A JP10677280 A JP 10677280A JP S5732226 A JPS5732226 A JP S5732226A
Authority
JP
Japan
Prior art keywords
affected part
exodontia
surgical operation
athlete
aggravation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10677280A
Other languages
Japanese (ja)
Inventor
Tetsuji Shimizu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HITOMI SETSUO
Original Assignee
HITOMI SETSUO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HITOMI SETSUO filed Critical HITOMI SETSUO
Priority to JP10677280A priority Critical patent/JPS5732226A/en
Publication of JPS5732226A publication Critical patent/JPS5732226A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PURPOSE: A nonionic pharmaceutical, containing lysozyme as an active constituent, and capable of preventing the growth of bacteria by the direct application to an affected part or external wound just after the surgical operation or exodontia with no irritant action.
CONSTITUTION: Lysozyme or lysozyme chloride is diluted with a carrier e.g. lactose, starch or a synthetic resin to about 5W10 times, and formulated into a pasty solution for use. The resultant pharmaceutical is directly applied to an affected part just after a surgical operation or exodontia or an exposed affected part of an external wound or athlete's foot to prevent the growth of bacteria. The treatment can be accelerated without showing the tendency to suppuration or aggravation. The substance is readily available and nontoxic to the human body even in a large amount.
COPYRIGHT: (C)1982,JPO&Japio
JP10677280A 1980-08-05 1980-08-05 Substance capable of preventing suppuration and aggravation by direct application to affected part just after surgical operation or exodontia or exposed affected part of external wound or athlete's foot Pending JPS5732226A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10677280A JPS5732226A (en) 1980-08-05 1980-08-05 Substance capable of preventing suppuration and aggravation by direct application to affected part just after surgical operation or exodontia or exposed affected part of external wound or athlete's foot

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10677280A JPS5732226A (en) 1980-08-05 1980-08-05 Substance capable of preventing suppuration and aggravation by direct application to affected part just after surgical operation or exodontia or exposed affected part of external wound or athlete's foot

Publications (1)

Publication Number Publication Date
JPS5732226A true JPS5732226A (en) 1982-02-20

Family

ID=14442191

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10677280A Pending JPS5732226A (en) 1980-08-05 1980-08-05 Substance capable of preventing suppuration and aggravation by direct application to affected part just after surgical operation or exodontia or exposed affected part of external wound or athlete's foot

Country Status (1)

Country Link
JP (1) JPS5732226A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4838771A (en) * 1987-06-03 1989-06-13 Nitto Kohki Co., Ltd. Biasing force adjusting apparatus for electromagnetically driven reciprocating pump
US7348301B2 (en) 2006-02-16 2008-03-25 Buckman Laboratories International, Inc. Lysozyme-based method and composition to control the growth of microorganisms in aqueous systems

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4838771A (en) * 1987-06-03 1989-06-13 Nitto Kohki Co., Ltd. Biasing force adjusting apparatus for electromagnetically driven reciprocating pump
US7348301B2 (en) 2006-02-16 2008-03-25 Buckman Laboratories International, Inc. Lysozyme-based method and composition to control the growth of microorganisms in aqueous systems

Similar Documents

Publication Publication Date Title
IE830207L (en) Fibrinogen formulation
ES2077530A1 (en) Pharmaceutical products for curing tumorous diseases and process for preparing same
JPS53118516A (en) Inactivation disinfectant of hepatitis-b virus
ES478967A1 (en) 3,7-Disubstituted-3-cephem-4-carboxylic acid compounds
ES8503643A1 (en) Biscarboxamides for treating diseases, and process for their preparation.
JPS52106836A (en) N-trichloroacetyl-n#-chlorobenzoylhydrazine derivatives and germicide s for agriculture and horticulture containing thereof
ZA784083B (en) Fatty acid and derivatives thereof,and formulations containing them for use in treatment or prophyllaxis of thrombo-embolic conditions
JPS5732226A (en) Substance capable of preventing suppuration and aggravation by direct application to affected part just after surgical operation or exodontia or exposed affected part of external wound or athlete's foot
EP0199117A3 (en) New therapeutical use of phosphocreatine
IE45054L (en) Veterinary composition
DE3784628D1 (en) DERMAL TREATMENT OF CAT WORM DISEASES WITH PRAZIQUANTEL.
DE3367592D1 (en) Novel derivatives of n,n-substituted azolecarboxamide and agricultural and horticultural fungicidal or nematicidal composition containing same as active ingredients
FR2525106B1 (en) COSMETIC COMPOSITION CONTAINING AS ACTIVE AGENT ON THE ELASTICITY AND FLEXIBILITY OF THE SKIN, THIAMORPHOLINONE OR ONE OF ITS DERIVATIVES
JPS5396388A (en) Preparation of l-phenylalanine
DE3373978D1 (en) Composition for the care or treatment of the human skin
JPS56156211A (en) Preparation of stable allantoin pharmaceutical
JPS5238013A (en) Sanitary treatment of materials used in contact with the skin
JPS5562005A (en) Skin cosmetic
JPH057361B2 (en)
JPS57142913A (en) Donor of physiologically active substance
JPS5423126A (en) Agricultural and horticultural fungicide
JPS5665825A (en) Remedy for peptic ulcer
JPS53127432A (en) Novel physiologically active substance, anthglutin, and its preparation
JPS53109938A (en) Insecticide
JPS5643209A (en) External drug of urokinase